 | • レポートコード：GIR-105X12409 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ネラチニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ネラチニブの種類別市場規模（40mg/180錠、40mg/150錠、40mg/90錠）、用途別市場規模（早期乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ネラチニブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Puma Biotechnology、Beacon Pharmaceuticals Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：40mg/180錠、40mg/150錠、40mg/90錠 ・用途別分析2016年-2026年：早期乳がん、その他 ・ネラチニブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ネラチニブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ネラチニブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ネラチニブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ネラチニブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Neratinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Neratinib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Neratinib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Neratinib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
40mg/180 Tablets
40mg/150 Tablets
40mg/90 Tablets
Market segment by Application can be divided into
Early Breast Cancer
Other
The key market players for global Neratinib market are listed below:
Puma Biotechnology
Beacon Pharmaceuticals Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Neratinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neratinib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 40mg/180 Tablets
1.2.3 40mg/150 Tablets
1.2.4 40mg/90 Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Neratinib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Early Breast Cancer
1.3.3 Other
1.4 Global Neratinib Market Size & Forecast
1.4.1 Global Neratinib Sales in Value (2016-2026))
1.4.2 Global Neratinib Sales in Volume (2016-2026)
1.4.3 Global Neratinib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Neratinib Production Capacity Analysis
1.5.1 Global Neratinib Total Production Capacity (2016-2026)
1.5.2 Global Neratinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neratinib Market Drivers
1.6.2 Neratinib Market Restraints
1.6.3 Neratinib Trends Analysis
2 Manufacturers Profiles
2.1 Puma Biotechnology
2.1.1 Puma Biotechnology Details
2.1.2 Puma Biotechnology Major Business
2.1.3 Puma Biotechnology Neratinib Product and Services
2.1.4 Puma Biotechnology Neratinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Beacon Pharmaceuticals Limited
2.2.1 Beacon Pharmaceuticals Limited Details
2.2.2 Beacon Pharmaceuticals Limited Major Business
2.2.3 Beacon Pharmaceuticals Limited Neratinib Product and Services
2.2.4 Beacon Pharmaceuticals Limited Neratinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Neratinib Sales by Manufacturer
3.1 Global Neratinib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neratinib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neratinib
3.4 Market Concentration Rate
3.4.1 Top 3 Neratinib Manufacturer Market Share
3.4.2 Top 6 Neratinib Manufacturer Market Share
3.5 Global Neratinib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neratinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neratinib Market Size by Region
4.1.1 Global Neratinib Sales in Volume by Region (2016-2026)
4.1.2 Global Neratinib Revenue by Region (2016-2026)
4.2 North America Neratinib Revenue (2016-2026)
4.3 Europe Neratinib Revenue (2016-2026)
4.4 Asia-Pacific Neratinib Revenue (2016-2026)
4.5 South America Neratinib Revenue (2016-2026)
4.6 Middle East and Africa Neratinib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neratinib Sales in Volume by Type (2016-2026)
5.2 Global Neratinib Revenue by Type (2016-2026)
5.3 Global Neratinib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neratinib Sales in Volume by Application (2016-2026)
6.2 Global Neratinib Revenue by Application (2016-2026)
6.3 Global Neratinib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neratinib Sales by Type (2016-2026)
7.2 North America Neratinib Sales by Application (2016-2026)
7.3 North America Neratinib Market Size by Country
7.3.1 North America Neratinib Sales in Volume by Country (2016-2026)
7.3.2 North America Neratinib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neratinib Sales by Type (2016-2026)
8.2 Europe Neratinib Sales by Application (2016-2026)
8.3 Europe Neratinib Market Size by Country
8.3.1 Europe Neratinib Sales in Volume by Country (2016-2026)
8.3.2 Europe Neratinib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neratinib Sales by Type (2016-2026)
9.2 Asia-Pacific Neratinib Sales by Application (2016-2026)
9.3 Asia-Pacific Neratinib Market Size by Region
9.3.1 Asia-Pacific Neratinib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neratinib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neratinib Sales by Type (2016-2026)
10.2 South America Neratinib Sales by Application (2016-2026)
10.3 South America Neratinib Market Size by Country
10.3.1 South America Neratinib Sales in Volume by Country (2016-2026)
10.3.2 South America Neratinib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neratinib Sales by Type (2016-2026)
11.2 Middle East & Africa Neratinib Sales by Application (2016-2026)
11.3 Middle East & Africa Neratinib Market Size by Country
11.3.1 Middle East & Africa Neratinib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neratinib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neratinib Typical Distributors
12.3 Neratinib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Neratinib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Neratinib Revenue by Application, (USD Million), 2021-2026
Table 3. Puma Biotechnology Basic Information, Manufacturing Base and Competitors
Table 4. Puma Biotechnology Major Business
Table 5. Puma Biotechnology Neratinib Product and Services
Table 6. Puma Biotechnology Neratinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Beacon Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 8. Beacon Pharmaceuticals Limited Major Business
Table 9. Beacon Pharmaceuticals Limited Neratinib Product and Services
Table 10. Beacon Pharmaceuticals Limited Neratinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Neratinib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Neratinib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Neratinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Neratinib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Neratinib Production Site of Key Manufacturer
Table 16. Global Neratinib Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Neratinib Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Neratinib Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Neratinib Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Neratinib Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Neratinib Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Neratinib Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Neratinib Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Neratinib Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Neratinib Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Neratinib Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Neratinib Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Neratinib Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Neratinib Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Neratinib Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Neratinib Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Neratinib Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Neratinib Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Neratinib Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Neratinib Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Neratinib Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Neratinib Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Neratinib Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Neratinib Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Neratinib Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Neratinib Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Neratinib Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Neratinib Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Neratinib Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Neratinib Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Neratinib Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Neratinib Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Neratinib Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Neratinib Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Neratinib Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Neratinib Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Neratinib Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Neratinib Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Neratinib Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Neratinib Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Neratinib Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Neratinib Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Neratinib Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Neratinib Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Neratinib Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Neratinib Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Neratinib Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Neratinib Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Neratinib Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Neratinib Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Neratinib Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Neratinib Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Neratinib Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Neratinib Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Neratinib Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Neratinib Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Neratinib Typical Distributors
Table 75. Neratinib Typical Customers
List of Figures
Figure 1. Neratinib Picture
Figure 2. Global Neratinib Sales Market Share by Type in 2020
Figure 3. 40mg/180 Tablets
Figure 4. 40mg/150 Tablets
Figure 5. 40mg/90 Tablets
Figure 6. Global Neratinib Sales Market Share by Application in 2020
Figure 7. Early Breast Cancer
Figure 8. Other
Figure 9. Global Neratinib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 10. Global Neratinib Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Neratinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Neratinib Sales (2016-2026) & (K Pcs)
Figure 31. Global Neratinib Production Capacity (2016-2026) & (K Pcs)
Figure 32. Global Neratinib Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Neratinib Market Drivers
Figure 34. Neratinib Market Restraints
Figure 35. Neratinib Market Trends
Figure 36. Global Neratinib Sales Market Share by Manufacturer in 2020
Figure 37. Global Neratinib Revenue Market Share by Manufacturer in 2020
Figure 38. Neratinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Neratinib Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Neratinib Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Neratinib Sales Market Share by Region (2016-2026)
Figure 42. Global Neratinib Revenue Market Share by Region (2016-2026)
Figure 43. North America Neratinib Revenue (2016-2026) & (USD Million)
Figure 44. Europe Neratinib Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Neratinib Revenue (2016-2026) & (USD Million)
Figure 46. South America Neratinib Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Neratinib Revenue (2016-2026) & (USD Million)
Figure 48. Global Neratinib Sales Market Share by Type (2016-2026)
Figure 49. Global Neratinib Revenue Market Share by Type (2016-2026)
Figure 50. Global Neratinib Price by Type (2016-2026) & (USD/Pcs)
Figure 51. Global Neratinib Sales Market Share by Application (2016-2026)
Figure 52. Global Neratinib Revenue Market Share by Application (2016-2026)
Figure 53. Global Neratinib Price by Application (2016-2026) & (USD/Pcs)
Figure 54. North America Neratinib Sales Market Share by Country (2016-2026)
Figure 55. North America Neratinib Revenue Market Share by Country (2016-2026)
Figure 56. North America Neratinib Sales Market Share by Type (2016-2026)
Figure 57. North America Neratinib Sales Market Share by Application (2016-2026)
Figure 58. Europe Neratinib Sales Market Share by Country (2016-2026)
Figure 59. Europe Neratinib Revenue Market Share by Country (2016-2026)
Figure 60. Europe Neratinib Sales Market Share by Type (2016-2026)
Figure 61. Europe Neratinib Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Neratinib Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Neratinib Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Neratinib Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Neratinib Sales Market Share by Application (2016-2026)
Figure 66. South America Neratinib Sales Market Share by Country (2016-2026)
Figure 67. South America Neratinib Revenue Market Share by Country (2016-2026)
Figure 68. South America Neratinib Sales Market Share by Type (2016-2026)
Figure 69. South America Neratinib Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Neratinib Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Neratinib Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Neratinib Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Neratinib Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のエルトロンボパグ錠市場 2021：企業別、地域別、種類・用途別 The Eltrombopag Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の食洗機用タブレット市場 2021：企業別、地域別、種類・用途別 The Dishwasher Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のオシメルチニブ市場 2021：企業別、地域別、種類・用途別 The Osimertinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界のミルタザピン錠市場 2021：企業別、地域別、種類・用途別 The Mirtazapine Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のアモキシシリン分散錠（DT）市場 2021：企業別、地域別、種類・用途別 The Amoxicillin Dispersible Tablets (DT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …